Howard Trachtman Selected Research

Howard Trachtman Research Topics

Disease

38	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 04/2024 - 10/2004
37	Proteinuria 02/2024 - 02/2002
14	Nephrotic Syndrome (Syndrome, Nephrotic) 04/2024 - 09/2005
12	Chronic Renal Insufficiency 03/2024 - 02/2002
8	IGA Glomerulonephritis (IGA Nephropathy) 02/2024 - 10/2003
8	Hypertension (High Blood Pressure) 05/2023 - 08/2007
8	Chronic Kidney Failure (Chronic Renal Failure) 08/2022 - 08/2003
8	Kidney Diseases (Kidney Disease) 05/2022 - 10/2005
7	Renal Insufficiency (Renal Failure) 12/2023 - 08/2003
7	Albuminuria 04/2021 - 04/2013
6	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2023 - 09/2005
6	Infections 01/2014 - 09/2003
6	Hemolytic-Uremic Syndrome 12/2009 - 03/2002
5	Edema (Dropsy) 01/2022 - 08/2007
5	Fibrosis (Cirrhosis) 01/2018 - 10/2002
5	Diarrhea 12/2009 - 03/2002
4	Insulin Resistance 06/2017 - 04/2013
3	Disease Progression 01/2023 - 01/2019
3	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2019 - 07/2004
3	Neoplasms (Cancer) 01/2017 - 10/2012
3	Inflammation (Inflammations) 01/2016 - 03/2015
3	Hyperuricemia 12/2015 - 08/2003
3	Hypercholesterolemia 11/2015 - 11/2008
3	Diabetic Nephropathies (Diabetic Nephropathy) 10/2005 - 01/2002
2	Prehypertension 11/2015 - 09/2013
2	Anemia 10/2012 - 11/2011
2	Acidosis 01/2012 - 12/2003
2	Hematuria 08/2007 - 10/2003
2	Hereditary Nephritis (Alport Syndrome) 03/2006 - 02/2002
2	Juvenile gout 06/2005 - 08/2003
2	Ureteral Obstruction 10/2004 - 10/2002
1	Dyslipidemias (Dyslipidemia) 02/2024
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2022
1	Celiac Disease (Celiac Sprue) 04/2021
1	Epilepsy (Aura) 01/2021
1	Birth Weight (Birth Weights) 10/2020

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 02/2024 - 06/2005
25	CreatinineIBA 02/2024 - 04/2006
12	sparsentanIBA 04/2024 - 07/2017
10	SteroidsIBA 04/2024 - 09/2005
10	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2013
9	Angiotensin Receptor AntagonistsIBA 04/2024 - 08/2013
8	Irbesartan FDA LinkGeneric 03/2024 - 07/2017
5	Endothelins (Endothelin)IBA 04/2024 - 01/2023
5	Adalimumab (Humira)FDA Link 02/2016 - 01/2010
5	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2015 - 09/2005
4	ReninIBA 02/2024 - 10/2005
4	Apolipoprotein L1IBA 01/2023 - 11/2011
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2022 - 02/2002
4	Complement System Proteins (Complement)IBA 01/2022 - 12/2009
4	bisphenol AIBA 10/2020 - 04/2013
4	phthalic acid (phthalate)IBA 10/2020 - 09/2013
4	AlbuminsIBA 01/2016 - 02/2002
3	Immunosuppressive Agents (Immunosuppressants)IBA 02/2024 - 07/2015
3	AldosteroneIBA 02/2024 - 10/2004
3	Oxidants (Oxidizing Agents)IBA 01/2022 - 06/2017
3	zonulinIBA 01/2022 - 01/2019
3	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2022 - 01/2020
3	Uric Acid (Urate)IBA 01/2016 - 08/2003
3	Galactose (Galactopyranose)FDA LinkGeneric 07/2015 - 03/2011
3	Shiga Toxin (Shigella Toxin)IBA 01/2014 - 09/2003
3	UromodulinIBA 11/2011 - 08/2003
2	AngiotensinsIBA 02/2024 - 10/2005
2	LipidsIBA 02/2024 - 11/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 01/2018
2	GlucocorticoidsIBA 01/2023 - 08/2009
2	Serum AlbuminIBA 01/2022 - 08/2020
2	Lipocalin-2IBA 01/2022 - 01/2020
2	Immunoglobulin A (IgA)IBA 01/2019 - 03/2006
2	ElectrolytesIBA 01/2019 - 01/2012
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2018 - 02/2002
2	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2014
2	Abatacept (Orencia)FDA Link 01/2018 - 03/2015
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2017 - 11/2015
2	Urokinase Plasminogen Activator ReceptorsIBA 11/2015 - 07/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2015 - 02/2011
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2015 - 10/2011
2	Dexamethasone (Maxidex)FDA LinkGeneric 06/2015 - 10/2011
2	Rituximab (Mabthera)FDA Link 03/2015 - 01/2011
2	Antifibrotic AgentsIBA 03/2015 - 01/2010
2	Hemoglobins (Hemoglobin)IBA 10/2012 - 06/2004
2	Tiopronin (Thiola)FDA Link 10/2005 - 12/2004
2	AntibodiesIBA 10/2004 - 07/2004
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2004 - 10/2002
2	NitritesIBA 10/2002 - 02/2002
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2002 - 01/2002
1	Environmental Pollutants (Pollutants, Environmental)IBA 03/2024
1	TRPC6 Cation ChannelIBA 12/2023
1	Antihypertensive Agents (Antihypertensives)IBA 05/2023
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022
1	danicopanIBA 01/2022
1	OrganophosphatesIBA 10/2021
1	Immunoglobulin M (IgM)IBA 10/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021

Therapy/Procedure

30	Therapeutics 02/2024 - 02/2002
3	Gluten-Free Diet 01/2022 - 01/2016
3	Kidney Transplantation 01/2016 - 01/2011
2	Renal Replacement Therapy (Therapies, Renal Replacement) 08/2015 - 05/2014
1	Aftercare (After-Treatment) 01/2021